Metallothionein-I/II null cardiomyocytes are sensitive to Fusarium mycotoxin butenolide-induced cytotoxicity and oxidative DNA damage

Toxicon

Volumn 55, Issue 7, 2010, Pages 1291-1296

  Yang, Hai Ying ^a,b   Wang, Yi Mei ^a   Peng, Shuang Qing ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b BEIJING INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY   (China)

Author keywords

Butenolide; Cardiomyocyte; Cytotoxicity; DNA damage; Metallothionein; ROS

Indexed keywords

BUTENOLIDE; DNA; METALLOTHIONEIN I; METALLOTHIONEIN II; MYCOTOXIN; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CARDIOTOXICITY; CELL STRUCTURE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA DAMAGE; DRUG CYTOTOXICITY; ENZYME INHIBITION; ENZYME SYNTHESIS; FUSARIUM; HEART MUSCLE CELL; HEART PROTECTION; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

4-BUTYROLACTONE; ANIMALS; CELL SURVIVAL; CELLS, CULTURED; COMET ASSAY; DNA DAMAGE; FUSARIUM; INDICATORS AND REAGENTS; METALLOTHIONEIN; MICE; MICE, KNOCKOUT; MYCOTOXINS; MYOCYTES, CARDIAC; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

FUSARIUM; MUS;

EID: 77951652952     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxicon.2010.01.022     Document Type: Article

References (33)

1. Bergamini C.M., Gambetti S., Dondi A., Cervellati C. Oxygen, reactive oxygen species and tissue damage. Curr. Pharm. Des. 2004, 10:1611-1626.
2. Cai L., Wang J., Li Y., Sun X., Wang L., Zhou Z., Kang Y.J. Inhibition of superoxide generation and associated nitrosative damage is involved in metallothionein prevention of diabetic cardiomyopathy. Diabetes 2005, 54:1829-1837.
3. Cai L., Wang Y., Zhou G., Chen T., Song Y., Li X., Kang Y.J. Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy. J. Am. Coll. Cardiol. 2006, 48:1688-1697.
4. Jia G., Sone H., Nishimura N., Satoh M., Tohyama C. Metallothionein (I/II) suppresses genotoxicity caused by dimethylarsinic acid. Int. J. Oncol. 2004, 25:325-333.
5. Kimura T., Fujita I., Itoh N., Muto N., Nakanishi T., Takahashi K., Azuma J., Tanaka K. Metallothionein acts as a cytoprotectant against doxorubicin toxicity. J. Pharmacol. Exp. Ther. 2000, 292:299-302.
6. Klein J.B., Wang G.W., Zhou Z., Buridi A., Kang Y.J. Inhibition of tumor necrosis factor-alpha-dependent cardiomyocyte apoptosis by metallothionein. Cardiovasc. Toxicol. 2002, 2:209-218.
7. Kumari M.V., Hiramatsu M., Ebadi M. Free radical scavenging actions of metallothionein isoforms I and II. Free Radic. Res. 1998, 29:93-101.
8. Lazo J.S., Kondo Y., Dellapiazza D., Michalska A.E., Choo K.H., Pitt B.R. Enhanced sensitivity to oxidative stress in cultured embryonic cells from transgenic mice deficient in metallothionein I and II genes. J. Biol. Chem. 1995, 270:5506-5510.
9. Liang Q., Carlson E.C., Donthi R.V., Kralik P.M., Shen X., Epstein P.N. Overexpression of metallothionein reduces diabetic cardiomyopathy. Diabetes 2002, 51:174-181.
10. Liu J., Liu Y., Hartley D., Klaassen C.D., Shehin-Johnson S.E., Lucas A., Cohen S.D. Metallothionein-I/II knockout mice are sensitive to acetaminophen-induced hepatotoxicity. J. Pharmacol. Exp. Ther. 1999, 289:580-586.
11. Liu J.B., Peng S.Q., Yang H.Y., Wang G.Q. Effect of butenolide on the activities of complex I-IV in the respiratory chain of myocardium mitochondria. J. Toxicol. 2005, 19:18-20. (in Chinese).
12. Liu J.B., Wang Y.M., Peng S.Q., Han G., Dong Y.S., Yang H.Y., Yan C.H., Wang G.Q. Toxic effects of Fusarium mycotoxin butenolide on rat myocardium and primary culture of cardiac myocytes. Toxicon 2007, 50:357-364.
13. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J.Immunol. Methods 1983, 65:55-63.
14. Pourahmad J., O'Brien P.J., Jokar F., Daraei B. Carcinogenic metal induced sites of reactive oxygen species formation in hepatocytes. Toxicol in Vitro 2003, 17:803-810.
15. Ren J., Privratsky J.R., Yang X., Dong F., Carlson E.C. Metallothionein alleviates glutathione depletion-induced oxidative cardiomyopathy in murine hearts. Crit. Care Med. 2008, 36:2106-2116.
16. Sato M., Bremner I. Oxygen free radicals and metallothionein. Free Radic. Biol. Med. 1993, 14:325-337.
17. Sato M., Kondoh M. Recent studies on metallothionein: protection against toxicity of heavy metals and oxygen free radicals. Tohoku J. Exp. Med. 2002, 196:9-22.
18. Shuai Y., Guo J.B., Peng S.Q., Zhang L.S., Guo J., Han G., Dong Y.S. Metallothionein protects against doxorubicin-induced cardiomyopathy through inhibition of superoxide generation and related nitrosative impairment. Toxicol. Lett. 2007, 170:66-74.
19. Singh N.P., Stephens R.E. Microgel electrophoresis: sensitivity, mechanisms, and DNA electro stretching. Mutat. Res. 1997, 383:167-175.
20. Sun X., Zhou Z., Kang Y.J. Attenuation of doxorubicin chronic toxicity in metallothionein-overexpressing transgenic mice heart. Cancer Res. 2001, 61:3382-3387.
21. Toth A., Nickson P., Qin L.L., Erhardt P. Differential regulation of cardiomyocyte survival and hypertrophy by MDM2, an E3 ubiquitin ligase. J. Biol. Chem. 2006, 281:3679-3689.
22. Vasák M., Hasler D.W. Metallothionein: new functional and structural insights. Curr. Opin. Chem. Biol. 2000, 4:177-183.
23. Wang G.W., Kang Y.J. Inhibition of doxorubicin toxicity in cultured neonatal mouse cardiomyocytes with elevated metallothionein levels. J. Pharmacol. Exp. Ther. 1999, 288:938-944.
24. 2 toxicity. Am. J. Physiol. Heart Circ. Physiol. 1999, 276:167-175.
25. Wang J., Song Y., Elsherif L., Song Z., Zhou G., Prabhu S.D., Saari J.T., Cai L. Cardiac metallothionein induction plays the major role in the prevention of diabetic cardiomyopathy by zinc supplementation. Circulation 2006, 113:544-554.
26. Wang Y.M., Peng S.Q., Zhou Q., Wang M.W., Yan C.H., Yang H.Y., Wang G.Q. Depletion of intracellular glutathione mediates butenolide-induced cytotoxicity in HepG2 cells. Toxicol. Lett. 2006, 164:231-238.
27. Wang Y.M., Peng S.Q., Zhou Q., Wang M.W., Han G., Yan C.H., Yang H.Y., Wang G.Q. Role of mitochondria in cellular oxidative injuries induced by butenolide. Chin. J. Pharmacol. Toxicol. 2006, 20:484-489. (in Chinese).
28. Wang Y.M., Wang H.J., Peng S.Q. Lipid peroxidation and antioxidant defense impairment in the hearts of chick embryos induced by in ovo exposure to Fusarium mycotoxin butenolide. Toxicon 2008, 52:781-786.
29. Yang H.Y., Wang Y.M., Peng S.Q. Basal expression of metallothionein suppresses butenolide-induced oxidative stress in liver homogenates in vitro. Toxicon 2009, 53:246-253.
30. Zhang W.X., Yin X.Y., Liu H., Chi Y.M., Yu W.H. Experimental study of myocardial injury induced by T-2 toxin. Chin. J. Endemiol. 2001, 20:28-30.
31. Zhao D., Feng Q., Yan X., Li C., Pan Y., Cui Q. Ultrastructural study of moniliformin induced lesions of myocardium in rats and mice. Biomed. Environ. Sci. 1993, 6:37-44.
32. Zheng H., Liu J., Liu Y., Klaassen C.D. Hepatocytes from metallothionein-I and II knock-out mice are sensitive to cadmium- and tert-butylhydroperoxide-induced cytotoxicity. Toxicol. Lett. 1996, 87:139-145.
33. Zhou Z., Sun X., Kang Y.J. Metallothionein protection against alcoholic liver injury through inhibition of oxidative stress. Exp. Biol. Med. 2002, 227:214-222.